The University of Maryland Medical Center (UMMC) announced the first successful transplant of a genetically modified pig’s heart into a human patient took place Jan. 9, 2022. The innovative procedure may pave the way to eliminating the current heart transplant wait lists. The cardiologists who developed this procedure believe in the near future, an unlimited number of pig hearts could be used to allow heart transplants in any patients who need them on demand, and regardless of the medical requirements that currently limit access to human heart transplants.
Cardiac surgeons Muhammad M. Mohiuddin, M.D., scientific and program director, Cardiac Xenotransplantation Program, University of Maryland, and Bartley P. Griffith, M.D., M.D., explain how the procedure and technology works. They surgically transplanted a pig heart into the human patient after the patient had no options left and did not qualify for the heart transplant list. The patient was surviving in the hospital only through the use of an ECMO heart-lung machine.
The patient, 57-year-old Maryland resident David Bennett, was granted a FDA emergency authorization for the surgery on New Year’s Eve through its expanded access (compassionate use) provision. It is used when an experimental medical product, in this case the genetically-modified pig’s heart, is the only option available for a patient faced with end-stage heart failure, a serious or life-threatening medical condition. The authorization to proceed was granted in the hope of saving the patient’s life.
“This was a breakthrough surgery and brings us one step closer to solving the organ shortage crisis. There are simply not enough donor human hearts available to meet the long list of potential recipients,” said Griffith, the Thomas E. and Alice Marie Hales Distinguished Professor in Transplant Surgery at UMSOM. “We are proceeding cautiously, but we are also optimistic that this first-in-the-world surgery will provide an important new option for patients in the future.”
This video includes video footage from the historic procedure and interviews with Griffith, Mohiuddin and other officials at University of Maryland Medical Center and the University of Maryland School of Medicine.
Read more in the article First Human Receives a Pig Heart Transplant.
1785 ViewsRecent Videos View all 644 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Sponsored Videos View all 46 items
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.
Watch the video to check out how TrueVue can help improve views of LAA and MV morphology.
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*
Watch the video to see how you can put “smart” to work with the latest AI-powered quantification tools.
*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer.
Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more.
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.
Conference Coverage View all 460 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cath Lab View all 316 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Imaging View all 287 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Cardiac Diagnostics View all 78 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
EP Lab View all 83 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
Information Technology View all 169 items
Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val Kapitula, partner, Paragon Consulting Partners LLC, about some of the trends he is seeing emerge in this field.
Related content:
RSNA 2022 Theme in Action: Empowering Patients and Partners in Care
Photo Gallery of Radiology Technology, Highlights from RSNA 2022
RSNA 2022 Day 4: Back to Basics on AI, ABUS Training, and ML in RO
RSNA 2022 Plenary Speaker Omary Urges Radiologists to Support Patients, Communities and the Planet
RSNA 2022: Innovative Solutions on Display, Leadership Addresses Value of Imaging
RSNA 2022 Day 2: Focus on Breast Screening & AI, Future of Patient Care
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, moderated a late-breaker session on Clinical Science in Structural Heart Disease. Here, she highlights the key results of the clinical trials for DAIC/dicardiology.com.
Related TCT 2022 Coverage:
VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional Cardiology Health Initiative; and Associate Professor, Harvard Medical School, presented on Precision Cardiovascular Medicine. She spoke with DAIC about some of the goals of precision medicine and how this data can be used.
Related TCT 2022 Coverage:
VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital, presented a late-breaker session on Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertensions: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial. He spoke with DAIC editors about the outcomes.
Related TCT 2022 Coverage:
VIDEO: Unique Features of Coronary Artery Disease in Women
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
Photo Gallery Highlighting TCT 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award
TCT 2022 Announces Winner of Shark Tank Innovation Award
Educational Leaders Join Forces on Educational Opportunities
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)